Progyny Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Progyny Inc (PGNY)
Progyny Inc stock price live, this page displays NASDAQ PGNY stock exchange data. View the PGNY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Progyny Inc real time stock price chart below.
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 23.67.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is ""PGNY.""
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
What Is the Progyny Inc Stock Price Today?
The Progyny Inc stock price today is 23.67.
What Is the Stock Symbol for Progyny Inc?
The stock symbol for Progyny Inc is ""PGNY.""
What Stock Exchange Does Progyny Inc Trade On?
Progyny Inc is listed and trades on the NASDAQ stock exchange.
Is Progyny Inc a Good Stock to Buy?
Determining whether Progyny Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PGNY quote. (ISIN: US74340E1038)
Fair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.17
23.88
52 wk Range
13.39
26.76
PGNY Scorecard
Full Analysis
Management has been aggressively buying back shares
PGNY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
23.1723.88
52 wk Range
13.3926.76
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PGNY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Progyny's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
28.25
Upside
+19.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Progyny Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Progyny (PGNY) director Gordon sells $55k in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Progyny Inc Company Profile
Progyny, Inc., a benefits management company, provides fertility, family building, and women’s health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Progyny Inc SWOT Analysis
Market Dynamics | Explore Progyny's position in the expanding fertility benefits market, projected to reach $50 billion by 2030, and its innovative approach to comprehensive coverage |
Financial Challenges | Delve into Progyny's recent setbacks, including the loss of a major client and lowered revenue guidance, balanced against its strong cash position and profitability |
Strategic Expansion | Learn about Progyny's foray into maternity and menopause programs, potentially offsetting recent losses and contributing significantly to future revenue growth |
Analyst Outlook | Discover varied analyst perspectives, with price targets ranging from $22 to $30, reflecting both optimism about long-term potential and concerns over near-term headwinds |
Progyny Inc Earnings Call Summary for Q2/2025
- Progyny Q2 2025 adjusted EPS of $0.48 beat forecasts by 200%, with revenue up 9.5% YoY to $332.9 million
- Despite strong results, stock fell 1.83% in aftermarket trading to $23.06
- Company expanded product offerings and global services, anticipating continued client base and covered lives growth
- Full-year revenue projected at $1.235-$1.270 billion, with adjusted EBITDA of $205.5-$214.5 million
- Management highlighted client diversity as key strength, with 81% of HR leaders committed to advancing women's health
Last Updated: 08/08/2025, 11:56
Read Full TranscriptCompare PGNY to Peers and Sector
Metrics to compare | PGNY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPGNYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.3x | −0.1x | −0.5x | |
PEG Ratio | −5.24 | 0.03 | 0.00 | |
Price/Book | 4.0x | 1.0x | 2.6x | |
Price / LTM Sales | 1.6x | 0.9x | 3.3x | |
Upside (Analyst Target) | 22.5% | 37.0% | 38.9% | |
Fair Value Upside | Unlock | 3.2% | 5.4% | Unlock |
Analyst Ratings
5 Buy
5 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 28.25
(+19.35% Upside)
Earnings
Latest Release
Aug 07, 2025
EPS / Forecast
0.48 / 0.16
Revenue / Forecast
332.84M / 317.61M
People Also Watch
FAQ
What Stock Exchange Does Progyny Trade On?
Progyny is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Progyny?
The stock symbol for Progyny is "PGNY."
What Is the Progyny Market Cap?
As of today, Progyny market cap is 2.04B.
What Is Progyny's Earnings Per Share (TTM)?
The Progyny EPS (TTM) is 0.61.
When Is the Next Progyny Earnings Date?
Progyny will release its next earnings report on 29 Oct 2025.
From a Technical Analysis Perspective, Is PGNY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Progyny Stock Split?
Progyny has split 0 times.
How Many Employees Does Progyny Have?
Progyny has 678 employees.
What is the current trading status of Progyny (PGNY)?
As of 30 Aug 2025, Progyny (PGNY) is trading at a price of 23.67, with a previous close of 23.25. The stock has fluctuated within a day range of 23.17 to 23.88, while its 52-week range spans from 13.39 to 26.76.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.